Respiratory Muscle Paralysis Associated With Colistin, Polymyxin B, and Muscle Relaxants Drugs: A Case Report

Journal of Investigative Medicine High Impact Case Reports

Volumn 4, Issue 1, 2016, Pages

  Myint, Thein ^a   Evans, Martin E ^a   Burgess, Donna R ^b   Greenberg, Richard N ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

colistin; muscle relaxant drugs; polymyxin B; respiratory muscle paralysis

Indexed keywords

CEFEPIME; COLISTIMETHATE; COLISTIN; CYCLOBENZAPRINE; FLUCONAZOLE; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; TISSUE PLASMINOGEN ACTIVATOR; TIZANIDINE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CANDIDA ALBICANS; CASE REPORT; DIABETES MELLITUS; DIAPHRAGM PARALYSIS; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; LAMINECTOMY; MALE; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; MUSCLE SPASM; OSTEOARTHRITIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SLURRED SPEECH; VERTEBRAL CANAL STENOSIS; WOUND INFECTION;

EID: 85050579821     PISSN: None     EISSN: 23247096     Source Type: Journal    
DOI: 10.1177/2324709616638362     Document Type: Article

References (18)

1. Koch-Weser J, Sidel VW, Federman EB, Kanarek P, Finer DC, Eaton AE., Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. Ann Intern Med. 1970;72:857-868.
2. Lindesmith LA, Baines RD, Jr Bigelow DB, Petty TL., Reversible respiratory paralysis associated with polymyxin therapy. Ann Intern Med. 1968;68:318-327.
3. Lee C, de Silva AJ., Interaction of neuromuscular blocking effects of neomycin and polymyxin B. Anesthesiology. 1979;50:218-220.
4. Zauder HL, Barton N, Bennett EJ, Lore J., Colistimethate as a cause of postoperative apnoea. Can Anaesth Soc J. 1966;13:607-610.
5. Burkett L, Bikhazi GB, Thomas KC, Jr Rosenthal DA, Wirta MG, Foldes FF., Mutual potentiation of the neuromuscular effects of antibiotics and relaxants. Anesth Analg. 1979;58:107-115.
6. de Gouw NE, Crul JF, Vandermeersch E, Mulier JP, van Egmond J, Van Aken H., Interaction of antibiotics on pipecuronium-induced neuromuscular blockade. J Clin Anesth. 1993;5:212-215.
7. Zusman O, Avni T, Leibovici L. Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenems. Antimicrob Agents Chemother. 2013;57:5104-5111.
8. Brunton LL, Chabner BA, Knollmann BC, eds. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, NY: McGraw-Hill; 2011.
9. Falagas ME, Kasiakou SK., Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care. 2006;10:R27.
10. Fekety FR, Jr Norman PS, Cluff LE., The treatment of gram-negative bacillary infections with colistin. The toxicity and efficacy of large doses in forty-eight patients. Ann Intern Med. 1962;57:214-229.
11. Wahby K, Chopra T, Chandrasekar P., Intravenous and inhalational colistin-induced respiratory failure. Clin Infect Dis. 2010;50:e38-e40.
12. Spapen HD, Honore PM, Gregoire N. Convulsions and apnoea in a patient infected with New Delhi metallo-beta-lactamase-1 Escherichia coli treated with colistin. J Infect. 2011;63:468-470.
13. Wunsch H, Moitra VK, Patel M, Dzierba AL., Polymyxin use associated with respiratory arrest. Chest. 2012;141:515-517.
14. Fernandez AB, Perez M, Soto L., Sudden respiratory muscle paralysis and apnea in a patient infected with multidrug-resistant Pseudomonas aeruginosa treated with intravenous colistin. Int J Infect Dis. 2013;17:e357.
15. Wadia S, Tran B., Colistin-mediated neurotoxicity. BMJ Case Rep. 2014;2014. doi:10.1136/bcr-2014-205332.
16. Shrestha A, Soriano SM, Song M, Chihara S., Intravenous colistin-induced acute respiratory failure: a case report and a review of literature. Int J Crit Illness Inj Sci. 2014;4:266-270.
17. Nigam A, Kumari A, Jain R, Batra S., Colistin neurotoxicity: revisited. BMJ Case Rep. 2015;2015. doi:10.1136/bcr-2015-210787.
18. Naranjo CA, Shear NH, Lanctot KL., Advances in the diagnosis of adverse drug reactions. J Clin Pharmacol. 1992;32:897-904.